Where does Thuasne rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Thuasne ranks #30,415 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Thuasne hold?

Thuasne holds 9 US utility patents granted between 2017 and 2025, spanning 9 technology areas.

What is Thuasne's Innovation Score?

Thuasne has an Innovation Score of 34.6 out of 100 (48th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Thuasne's patent grant rate increasing or decreasing?

Thuasne's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Thuasne's patents?

Thuasne's patents average 18.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Thuasne patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Thuasne

Q: What technology areas does Thuasne focus on?

Thuasne's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 8 patents. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Thuasne ranks #30,415 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 9 technology areas.

#30,415
of 49,997 US assignees by volume: 48th percentile
by Innovation Score (34.6/100): 18.4
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R30415 · Foreign Corporation #30,415 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #30,415/49,997
PHOTO-FINISH Thinxtream PTE
CPC-NARROW A61F · 9 areas
INNOV-THIN 34.6/100
CLAIMS-RICH 18.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Thinxtream Technologies PTE. Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Thuasne · this assignee

35
3D Lighting… · lowest

7

What this shows Thuasne's Innovation Score is 34.6/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Thuasne's grants concentrate

Thuasne is a focused PatentsView assignee: 9 CPC subclasses with 88.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2017. By volume, Thuasne sits between Thinxtream Technologies PTE. Ltd. and TLI Inc..

Thuasne's three-year grant acceleration

Thuasne shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Thinxtream PTE

9
Thorium Power

9
Thorne Intellectu…

9
Three Smith Group

9
Tianjin Asymchem…

9
Tianjin Tianchuan…

9
Tinavi Medical

9
TLI

9
Thuasne ◀

9

What this shows Thuasne holds 9 patents at rank #30,335, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Thuasne

By rank, the assignees closest to #30,335 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Thuasne's primary technology class.

Thuasne's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Thuasne patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	11.1%
2019	3	33.3%
2021	1	11.1%
2024	3	33.3%
2025partial year	1	11.1%

Which technologies does Thuasne patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 8

D04B - Knitting 3

D10B - Indexing Scheme Associated With Sublasses OF Section D, Relating TO Textiles 2

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 2

Y10T - Technical Subjects Covered BY Former US Classification 2

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 1

D03D - Woven FABRICS; Methods OF WEAVING; Looms 1

D02G - Crimping OR Curling Fibres, Filaments, Threads, OR YARNS; Yarns OR Threads 1

A41B - SHIRTS; UNDERWEAR; Baby LINEN; Handkerchiefs 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#30,415

of 49,997 tracked assignees

Innovation Score

34.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Thuasne's patent record in context - here's where to go next.

Thuasne's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 88.9% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #30,415 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Thuasne against Thinxtream Technologies PTE. Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.